Levitee Labs Inc.
Levitee Labs Inc.
Indice CSE:
Devise:
Levitee Labs is a multidisciplinary integrative wellness company that’s redefining mental healthcare through a preventative, restorative, and transformative approach that includes evidence-based alternative medicines and novel psychedelic therapies.
Through a vertically integrated and disciplined M&A model, our core objective is a progressive push towards the introduction of novel treatment modalities, with a key focus on the integration of evidence-based psychedelic medicines and therapies. This model addresses the burden of inefficiencies prevalent within current clinical treatments, particularly those available to underserved patient populations.
Levitee Labs Inc. (LVT)
SEDAR Information
Information d'entreprise
Addresse
215, 800 West Pender St.
Vancouver, BC V6C 1J8
CanadaTéléphone
250-465-8640Courriel
[email protected]URL
https://leviteelabs.comDate d’inscription à la cote
Mercredi, juillet 21, 2021
Agent de transfert
Odyssey Trust CompanyCapitalisation
Capitalisation:
80112564Réservé à l'émission:
18957485Company Officers
Pouya Farmand, Chief Executive Officer
Mason Darabi , Chief Financial Officer
Communiqués de presse
Bulletins
06/02/2023
2023-0203 - Suspensions (BLMH, EGFV, GHG, GHG.WT, GPK, LVT, PPK)
le 6 février/February 2023
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.